In a recent comment letter, PhRMA encouraged CMS to develop key education and outreach tools for beneficiaries on the Medicare Prescription Payment Plan program, to keep beneficiary protections at the forefront of operational calculations and effectuation decision-making, and not to delay decisions related to infrastructure and effectuation details. Our comments were intended to ensure the program meets its goal of improving affordability for Medicare beneficiaries.